Showing results (101-110 of 129) with videos related to
Sort By:
Pageof 13
International Journal of Molecular Sciences|January 23, 2024
Caveolin-3 and Caveolin-1 Interaction Decreases Channel Dysfunction Due to Caveolin-3 MutationsPatrizia Benzoni, Elisabetta Gazzerro, Chiara Fiorillo, et al.Journal of Molecular and Cellular Cardiology|July 26, 2017
D242N, a KV7.1 LQTS mutation uncovers a key residue for IKs voltage dependenceCristina Moreno, Anna Oliveras, Chiara Bartolucci, et al.European Journal of Nuclear Medicine and Molecular Imaging|May 21, 2020
Dosimetry and safety of 177Lu PSMA-617 along with polyglutamate parotid gland protector: preliminary results in metastatic castration-resistant prostate cancer patientsGiovanni Paganelli, Anna Sarnelli, Stefano Severi, et al.European Journal of Nuclear Medicine and Molecular Imaging|February 28, 2018
PRRT genomic signature in blood for prediction of 177Lu-octreotate efficacyLisa Bodei, Mark S Kidd, Aviral Singh, et al.BMJ Open|July 22, 2020
Randomised phase II trial of CAPTEM or FOLFIRI as SEcond-line therapy in NEuroendocrine CArcinomas and exploratory analysis of predictive role of PET/CT imaging and biological markers (SENECA trial): a study protocolAlberto Bongiovanni, Chiara Liverani, Sara Pusceddu, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 17, 2019
Ten-year experience of the multidisciplinary Osteoncology CenterAlberto Bongiovanni, Federica Recine, Valentina Fausti, et al.Cardiovascular Research|December 16, 2014
Marine n-3 PUFAs modulate IKs gating, channel expression, and location in membrane microdomainsCristina Moreno, Alicia de la Cruz, Anna Oliveras, et al.European Journal of Nuclear Medicine and Molecular Imaging|December 16, 2019
PRRT neuroendocrine tumor response monitored using circulating transcript analysis: the NETestLisa Bodei, Mark S Kidd, Aviral Singh, et al.European Journal of Nuclear Medicine and Molecular Imaging|February 19, 2021
Combined use of 177Lu-DOTATATE and metronomic capecitabine (Lu-X) in FDG-positive gastro-entero-pancreatic neuroendocrine tumorsSilvia Nicolini, Lisa Bodei, Alberto Bongiovanni, et al.Journal of Visualized Experiments : Jove|May 12, 2020
A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image MethodsMaria Luisa Belli, Emilio Mezzenga, Valentina Di Iorio, et al.Pageof 13